CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with Chemotherapy
The prominent desmoplastic stroma of pancreatic ductal adenocarcinoma (PDAC) is a determinant factor in tumor progression and a major barrier to the access of chemotherapy. The PDAC microenvironment therefore appears to be a promising therapeutic target. CCN2/CTGF is a profibrotic matricellular prot...
Main Authors: | Andrea Resovi, Patrizia Borsotti, Tommaso Ceruti, Alice Passoni, Massimo Zucchetti, Alexander Berndt, Bruce L. Riser, Giulia Taraboletti, Dorina Belotti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/4/952 |
Similar Items
-
The CCN family acting throughout the body: recent research developments
by: Kubota Satoshi, et al.
Published: (2013-10-01) -
Matricellular proteins of the Cyr61/CTGF/NOV (CCN) family and the nervous system
by: Anna R Malik, et al.
Published: (2015-06-01) -
Atrial expression of the CCN1 and CCN2 proteins in chronic heart failure
by: Lech Chyczewski, et al.
Published: (2012-04-01) -
CCN Family Proteins in Cancer: Insight Into Their Structures and Coordination Role in Tumor Microenvironment
by: Qingan Jia, et al.
Published: (2021-03-01) -
Targeting CCN Proteins in Rheumatoid Arthritis and Osteoarthritis
by: Iona J. MacDonald, et al.
Published: (2021-04-01)